Multimedia content is supported by an unrestricted educational grant from:

Scientific Agenda

Session IIA: The current state of antifungals (recent developments and happenings): The company research perspective
Moderator: Elias J. Anaissie, MD

Clinical applications of echinocandins: Addressing the most common caspofungin inquiries
Nicholas Kartsonis, MD

Micafungin alone and in combination
Donald Buell, MD

Emerging echinocandin therapies: Focus on aminocandin
Nova Najarian, RN

Azoles: Meeting the challenges in clinical drug development for serious fungal infections
Catherine J. Hardalo, MD

Recent clinical findings with applications of amphotericin B variants
Mark Bresnik, MD

Unique forms of amphotericin B
Michael J. Weickert, PhD

Unique forms of amphotericin B - ABLC and Beyond
Ivan Horak, MD